Coya Therapeutics is a clinical-stage biotechnology company developing proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. Its lead product candidate, COYA 101, an autologous regulatory T-cell product, has completed Phase 2a clinical trial for the treatment of Amyotrophic Lateral Sclerosis.
Frequently asked questions
Is Coya Therapeutics (COYA) stock halal to invest in?
No. As of , COYA is not Shariah-compliant under AAOIFI standards, so it is not considered halal to invest in. Coya Therapeutics fails the business screen, the financial screen or both, based on its most recent financial reports. The Zoya app shows which one and lists Shariah-compliant alternatives.
Does Coya Therapeutics have any interest income?
No, Coya Therapeutics has not reported any interest income. According to the company's latest annual
report for the fiscal year ending Dec 31, 2025, Coya Therapeutics reported total revenue
of 7945753, with no separate interest income disclosed. However,
it's worth noting that some companies may report interest income as part of their revenue. For a detailed
breakdown of all interest income and revenue segments, please refer to the full Shariah compliance
report available in the Zoya app.
What guidelines are used to determine if Coya Therapeutics stock is Shariah-compliant?
We use the guidelines set by the Accounting and Auditing Organization for Islamic Financial Institutions
(AAOIFI) to assess Shariah compliance. AAOIFI is a leading international organization that establishes
standards for Islamic finance. Their guidelines help determine if a company's business activities and
financial structure align with Islamic principles. These standards are widely respected in the Islamic
finance industry and provide a consistent framework for evaluating the Shariah compliance of stocks and
other financial instruments. AAOIFI's Shariah board includes renowned scholars such as Sheikh Muhammad
Taqi Usmani, Sheikh Mohamed Ali Elgari, Sheikh Abdullah AlManea, Sheikh Nizam Yaquby, and Dr. Aznan Hassan.
How often is Coya Therapeutics stock reviewed for Shariah compliance?
The Shariah compliance status of Coya Therapeutics stock is reviewed on a regular basis, with a minimum
frequency of once per quarter. However, if there are any significant changes or major developments
in the company's operations that may impact its compliance, an immediate review will be conducted to
ensure ongoing adherence to Shariah principles.
How can I stay updated on Coya Therapeutics's compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within
the Zoya app to receive notifications whenever there is a change in the Shariah compliance of COYA,
or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate
due to changes in a company's financial ratios or business activities.
Are dividends from Coya Therapeutics stock considered halal?
No, dividends from COYA are not considered halal because the stock is currently not
Shariah-compliant. When a stock is non-compliant, any dividends received from it are considered
impermissible income and should be donated to charity as a form of purification. To learn more about
the purification process and how to handle impermissible income, read
our comprehensive guide.
Do I need to pay Zakat on my Coya Therapeutics shares?
If you hold Coya Therapeutics stock as an investment, through an Employee Stock Ownership
Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and
meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on investments
can be complex and depends on various factors. To help make this easy, we've created a free
Zakat calculator for stocks. For a more
seamless experience, use the Zoya mobile app, where you can link your brokerage account to
automatically import holdings.
Community posts
Related stocks
See how Coya Therapeutics compares with its peers:
